Finance

Lists
ATGGF:OTCMKTS
Actinogen Medical Ltd
$0.035
0.00%
(0.00) 1D
Aug 27, 1:10:57 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATGGF...
Mkt. cap
224.99M
Avg. vol.
8.46K
Volume
0.00
52-wk high
$1.00
52-wk low
$0.00
Shares outstanding
3.75B
Mkt. cap
224.99M
Avg. vol.
8.46K
Volume
0.00
52-wk high
$1.00
52-wk low
$0.00
Shares outstanding
3.75B
News stories
From web sources and news partners
About Actinogen Medical Ltd
CEOSteven Gourlay
Employees-
Founded1999
Headquarters-
SectorBiotechnology
Websiteactinogen.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
937.07K
937.07K
5.40M
5.40M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.45M
4.45M
5.06M
5.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.56M
1.56M
1.91M
1.91M
Operating expense
6.64M
6.64M
7.42M
7.42M
Total operating expenses
6.64M
6.64M
7.42M
7.42M
Operating income
-5.70M
-5.70M
-2.02M
-2.02M
Other non operating income
-
-
-
-
EBT including unusual items
-5.67M
-5.67M
-2.02M
-2.02M
EBT excluding unusual items
-5.67M
-5.67M
-2.02M
-2.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.67M
-5.67M
-2.02M
-2.02M
Net profit margin
-605.45%
-605.45%
-37.34%
-37.34%
Earnings per share
-
-
-
-
Interest and investment income
116.46K
116.46K
133.47K
133.47K
Interest expense
-76.33K
-76.33K
-156.64K
-156.64K
Net interest expenses
40.13K
40.13K
-23.17K
-23.17K
Depreciation and amortization charges
27.15K
27.15K
26.11K
26.11K
EBITDA
-5.62M
-5.62M
-1.93M
-1.93M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps